Identification of a second Klotho interaction site in the C terminus of FGF23

被引:19
作者
Agrawal, Archita [1 ]
Ni, Pu [2 ]
Agoro, Rafiou [2 ]
White, Kenneth E. [2 ]
DiMarchi, Richard D. [1 ]
机构
[1] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA
[2] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
关键词
DOMINANT HYPOPHOSPHATEMIC RICKETS; ALPHA-KLOTHO; PHOSPHATE; MUTATIONS; TAIL; ABLATION; FGF-23;
D O I
10.1016/j.celrep.2020.108665
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
FGF23 interacts with a FGFR/KL-receptor complex to propagate cellular signaling, where its C-terminal C26 peptide is critical for engaging the co-receptor KL. We identify a distinct peptide sequence C28 residing in the FGF23 C terminus that regulates its interaction with KL. C28 can independently function as an FGF23 antagonist, and we report an optimized peptide antagonist of much enhanced potency. FGF23 can use either of the two C-terminal sites to exert biological effects, as shown by in vitro and in vivo studies. The loss of both KL-interaction sites inactivates the protein. We conclude that the C terminus of FGF23 is a bidentate ligand possessing two independent KL-interaction sites. The identification of this second KL-association site provides an additional perspective in the molecular basis of FGF23-receptor signaling and raises questions pertaining to its structural mechanism of action and the potential for biased biological signaling.
引用
收藏
页数:14
相关论文
共 32 条
[1]   Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia [J].
Agoro, Rafiou ;
Montagna, Anna ;
Goetz, Regina ;
Aligbe, Onyedikachi ;
Singh, Gurinder ;
Coe, Lindsay M. ;
Mohammadi, Moosa ;
Rivella, Stefano ;
Sitara, Despina .
FASEB JOURNAL, 2018, 32 (07) :3752-3764
[2]   Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity [J].
Agrawal, Archita ;
Parlee, Sebastian ;
Perez-Tilve, Diego ;
Li, Pengyun ;
Pan, Jia ;
Mroz, Piotr A. ;
Hansen, Ann Maria Kruse ;
Andersen, Birgitte ;
Finan, Brian ;
Kharitonenkov, Alexei ;
DiMarchi, Richard D. .
MOLECULAR METABOLISM, 2018, 13 :45-55
[3]   α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling [J].
Chen, Gaozhi ;
Liu, Yang ;
Goetz, Regina ;
Fu, Lili ;
Jayaraman, Seetharaman ;
Hu, Ming-Chang ;
Moe, Orson W. ;
Liang, Guang ;
Li, Xiaokun ;
Mohammadi, Moosa .
NATURE, 2018, 553 (7689) :461-+
[4]   Burosumab: At Long Last, an Effective Treatment for FGF23-Associated Hypophosphatemia [J].
Collins, Michael .
JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (08) :1381-1382
[5]   Genetic diseases resulting from disordered FGF23/klotho biology [J].
Econs, Michael J. .
BONE, 2017, 100 :56-61
[7]   Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis [J].
Garringer, Holly J. ;
Malekpour, Mahdi ;
Esteghamat, Fatemehsadat ;
Mortazavi, Seyed M. J. ;
Davis, Siobhan I. ;
Farrow, Emily G. ;
Yu, Xijie ;
Arking, Dan E. ;
Dietz, Harry C. ;
White, Kenneth E. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 295 (04) :E929-E937
[8]   Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation [J].
Goetz, Regina ;
Nakada, Yuji ;
Hu, Ming Chang ;
Kurosu, Hiroshi ;
Wang, Lei ;
Nakatani, Teruyo ;
Shi, Mingjun ;
Eliseenkova, Anna V. ;
Razzaque, Mohammed S. ;
Moe, Orson W. ;
Kuro-o, Makoto ;
Mohammadi, Moosa .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (01) :407-412
[9]   Therapeutic Effects of FGF23 c-tail Fc in a Murine Preclinical Model of X-Linked Hypophosphatemia Via the Selective Modulation of Phosphate Reabsorption [J].
Johnson, Kristen ;
Levine, Kymberly ;
Sergi, Joseph ;
Chamoun, Jean ;
Roach, Rachel ;
Vekich, Jacqueline ;
Favis, Mike ;
Horn, Mark ;
Cao, Xianjun ;
Miller, Brian ;
Snyder, William ;
Aivazian, Dikran ;
Reagan, William ;
Berryman, Edwin ;
Colangelo, Jennifer ;
Markiewicz, Victoria ;
Bagi, Cedo M. ;
Brown, Thomas P. ;
Coyle, Anthony ;
Mohammadi, Moosa ;
Magram, Jeanne .
JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (10) :2062-2073
[10]   Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. [J].
Jonsson, KB ;
Zahradnik, R ;
Larsson, T ;
White, KE ;
Sugimoto, T ;
Imanishi, Y ;
Yamamoto, T ;
Hampson, G ;
Koshiyama, H ;
Ljunggren, Ö ;
Oba, K ;
Yang, IM ;
Miyauchi, A ;
Econs, MJ ;
Lavigne, J ;
Jüppner, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1656-1663